Clinical Trials - Phase I
Filter News
Found 21,039 articles
-
ArQule, Inc. Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Oral Presentation at American Society of Clinical Oncology
3/15/2007
-
Neose Technologies, Inc. Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
3/15/2007
-
Ariadne Genomics, Inc. Receives SBIR Phase I Grant from National Institutes of Health (NIH)
3/15/2007
-
Sucampo Pharmaceuticals, Inc. Initiates Clinical Study of AMITIZA in Japan
3/14/2007
-
Nektar Therapeutics Initiates Phase 1 Clinical Program Evaluating NKTR-102 (PEG-irinotecan) for Potential to Treat Patients with Refractory Solid Tumors
3/13/2007
-
CeNeRx BioPharma, Inc. Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
3/13/2007
-
Enzo Therapeutics, Inc. Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections
3/13/2007
-
Active Biotech AB's I-3D Micro-dosing Clinical Trial Concluded
3/13/2007
-
Chemokine Therapeutics Corp. Announces Preliminary Results of CTCE-9908 Phase Ib/II Clinical Trial in Late Stage Cancer Patients
3/12/2007
-
TorreyPines Therapeutics, Inc. Initiates Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated With Schizophrenia
3/12/2007
-
Symphogen A/S And Biovitrum AB Initiate Phase 1 Clinical Trial with the First Recombinant Polyclonal Antibody to Enter Clinical Evaluation
3/12/2007
-
Liponex, Inc. Reports Phase I/II Clinical Trial Data for CRD5; Shares Plunge on Weak Results
3/9/2007
-
7TM Pharma Advances the Next First-in-class Obesity Compound Into Clinical Development
3/9/2007
-
Positive Clinical Data for TASQ - Active Biotech AB's Novel Treatment of Prostate Cancer
3/9/2007
-
Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin Phase I Clinical Trial in Pediatric Relapsed or Refractory Acute Leukemia
3/8/2007
-
Data From Adherex Technologies Inc.'s European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies
3/8/2007
-
MAT Biopharma Announced Today the Initiation of the Phase I/II Escalating Dose of Ferritarg P(R)
3/7/2007
-
Stemline Therapeutics, Inc. In-Licenses Phase I Oncology Compound
3/7/2007
-
Allon Therapeutics, Inc. Product AL-108 Successful in Phase Ib Clinical Trial
3/7/2007
-
Sunesis Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of SNS-032 in Patients With B-cell Malignancies
3/6/2007